Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

3D mammography shows promise as next breast screening technique

08.05.2003


“Full-field digital tomosynthesis is mammography--only better,” researchers say of a new technique that just might be the next generation of breast cancer screening. Two new studies on this technique illustrate that full-field digital tomosynthesis (TOMO) can not only increase the visibility of breast lesions but could likely dramatically reduce the number of patients being called back for a second mammogram because their first screening mammogram was unclear.



In the first study, researchers compared standard plain film mammography to TOMO. Forty patients were included in the study. Radiologists detected 16 of 22 malignant lesions on mammography and 18 of 22 malignant lesions on TOMO, says Elizabeth Rafferty, MD, lead author of both studies. TOMO was superior to plain film mammography in detecting masses and architectural distortions, which results from a tethering or pulling in of the tissue, says Dr. Rafferty. Calcifications were not as conspicuous on the tomosynthesis imaging during the pilot study, she says. “We are currently implementing a solution to this challenge and will have data on this soon,” she adds.

In the second study, 45 patients were reviewed. All patients had been called back for a second mammogram because their first showed a possible abnormality; “30 of them were subsequently found by additional mammographic views to have breast tissue overlap accounting for their possible abnormality,” she says. Fifteen patients went on to biopsy. “We asked radiologists to look at the TOMO study (without knowing the results of the second mammogram or biopsy) and indicate whether they would have called these patients back for additional evaluation,” says Dr. Rafferty. They indicated that they would have only called back five of the 30 patients who had breast tissue overlap. “If we could have used TOMO on these patients initially, it would have saved 25 women the anxiety they felt and the inconvenience they experienced of being called back for additional tests,” notes Dr. Rafferty.


The radiologists indicated that they would have recalled 14 of the 15 patients who had a biopsy, says Dr. Rafferty. A single reader missed one cancer, she says. “This is well within the standard interobserver variability seen with conventional mammography,” she adds.

“TOMO allows us to take multiple projections of the breast at different angles. These projections are then reconstructed into a three-dimensional data set. We can then look at each slice individually and assess each area of the breast without confusing overlap from surrounding structures,” Dr. Rafferty says. “The ability to look at individual slices of the breast is a real asset,” she says.

TOMO is more comfortable for the patient. The patient’s breasts only need to be compressed once (compared to twice for the standard two-view mammogram); the patient sits during the procedure, and the overall radiation dose is lower, says Dr. Rafferty. Dr. Rafferty cautions, however, that “full-field digital tomosynthesis is still in its infancy.” However, she predicts, “this technique will only get better.” Researchers at Massachusetts General Hospital conceived, developed, and patented full-field breast tomosynthesis, and, in conjunction with General Electric, built the only prototype currently in clinical use. To date, more than 350 clinical tomosynthesis studies have been performed at Massachusetts General Hospital under research protocols.


Dr. Rafferty will present the results of her studies on May 8 during the American Roentgen Ray Society Annual Meeting in San Diego.

Contact: Keri J. Sperry (703) 858-4306
Danica Laub (703) 858-4332
Press Room: (619) 525-6536 (May 5-8)

Keri Sperry | EurekAlert!
Further information:
http://www.arrs.org/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>